{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:05:12Z","timestamp":1790780712249,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019123","name":"Operation Eyesight Universal Institute for Eye Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019123","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005809","name":"Hyderabad Eye Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","surveyophthalmol.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.survophthal.2024.05.009","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T06:18:55Z","timestamp":1716531535000},"page":"697-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Role of MYCN in retinoblastoma: A review of current literature"],"prefix":"10.1016","volume":"69","author":[{"given":"Vijitha S.","family":"Vempuluru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Maniar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal","family":"Bakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swathi","family":"Kaliki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.survophthal.2024.05.009_bib1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ophtha.2019.12.005","article-title":"Next-generation sequencing of retinoblastoma identifies pathogenic alterations beyond rb1 inactivation that correlate with aggressive histopathologic features","volume":"127","author":"Afshar","year":"2020","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.survophthal.2024.05.009_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112925","article-title":"Deneddylation of ribosomal proteins promotes synergy between MLN4924 and chemotherapy to elicit complete therapeutic responses","volume":"42","author":"Aubry","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.survophthal.2024.05.009_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41420-020-0237-8","article-title":"Preclinical studies reveal MLN4924 is a promising new retinoblastoma therapy","volume":"6","author":"Aubry","year":"2020","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.survophthal.2024.05.009_bib4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fonc.2015.00278","article-title":"Aurora kinase inhibitors: current status and outlook","volume":"5","author":"Bavetsias","year":"2015","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.survophthal.2024.05.009_bib5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/genes10110879","article-title":"The RB1 story: characterization and cloning of the first tumor suppressor gene","volume":"10","author":"Berry","year":"2019","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.009_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41389-022-00409-3","article-title":"MYCN induces cell- specific tumorigenic growth in RB1-proficient human retinal organoid and chicken retina models of retinoblastoma","volume":"11","author":"Blixt","year":"2022","journal-title":"Oncogenesis"},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.009_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/iovs.62.3.16","article-title":"Aurora Kinase B expression, its regulation and therapeutic targeting in human retinoblastoma","volume":"62","author":"Borah","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2024.05.009_bib8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/gcc.20383","article-title":"Profiling genomic copy number changes in retinoblastoma beyond loss of RB1","volume":"46","author":"Bowles","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1016\/j.survophthal.2024.05.009_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095628","article-title":"Sunitinib suppress neuroblastoma growth through degradation of MYCN and inhibition of angiogenesis","volume":"9","author":"Calero","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.009_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1871520619666181231112453","article-title":"Crocetin and crocin from saffron in cancer chemotherapy and chemoprevention","volume":"19","author":"Colapietro","year":"2019","journal-title":"Anticancer Agents Med Chem"},{"issue":"7","key":"10.1016\/j.survophthal.2024.05.009_bib11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/gcc.20457","article-title":"One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma","volume":"46","author":"Corson","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1016\/j.survophthal.2024.05.009_bib12","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3390\/cancers13040754","article-title":"Whole-genome sequencing of retinoblastoma reveals the diversity of rearrangements disrupting RB1 and uncovers a treatment-related mutational signature","volume":"13","author":"Davies","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.009_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22292","article-title":"Crocin inhibits proliferation and induces apoptosis through suppressing MYCN expression in retinoblastoma","volume":"33","author":"Deng","year":"2019","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.009_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jnr.24213","article-title":"Retinoblastoma, the visible CNS tumor: a review","volume":"97","author":"Dimaras","year":"2019","journal-title":"J Neurosci Res"},{"issue":"4","key":"10.1016\/j.survophthal.2024.05.009_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0002-9394(64)91368-6","article-title":"The story of retinoblastoma. The XX Edward Jackson memorial lecture","volume":"58","author":"Dunphy","year":"1964","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.009_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/cam4.1010","article-title":"Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma","volume":"6","author":"Ewens","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.survophthal.2024.05.009_bib17","unstructured":"Gene [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2023 \u2013 [cited 2024 01 22] Available from: https:\/\/wwwncbinlmnihgov\/gene?Db=gene&Cmd=DetailsSearch&Term=4613."},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.009_bib18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2217\/14796694.3.5.575","article-title":"Role of DEAD box 1 in retinoblastoma and neuroblastoma","volume":"3","author":"Godbout","year":"2007","journal-title":"Future Oncol"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.009_bib19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ajo.2014.07.025","article-title":"Retinoblastoma Fifty years of progress The LXXI Edward Jackson Memorial Lecture","volume":"158","author":"Grossniklaus","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2024.05.009_bib20","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00595-019-01790-0","article-title":"The roles played by the MYCN, Trk, and ALK genes in neuroblastoma and neural development","volume":"49","author":"Higashi","year":"2019","journal-title":"Surg Today"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.009_bib21","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222264","article-title":"MRI Features for Identifying MYCN-amplified RB1 Wild-type Retinoblastoma","volume":"307","author":"Jansen","year":"2023","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.survophthal.2024.05.009_bib22","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.survophthal.2024.05.009_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/srep25264","article-title":"Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes","volume":"6","author":"Kooi","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2024.05.009_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbrc.2021.07.099","article-title":"MiR-142-5p serves as a tumor suppressor in retinoblastoma cells by regulating MYCN","volume":"574","author":"Li","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.survophthal.2024.05.009_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.623679","article-title":"Targeting MYCN in pediatric and adult cancers","volume":"10","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.009_bib26","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1038\/s41467-021-25792-0","article-title":"A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal\/ganglion cell gene expression","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.survophthal.2024.05.009_bib27","unstructured":"Lohmann D.R., Gallie B.L. Retinoblastoma. 2000 Jul 18 [updated 2023 Sep 21] In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors GeneReviews\u00ae [Internet] Seattle (WA): University of Washington, Seattle; 1993\u20132024 PMID: 20301625."},{"issue":"9","key":"10.1016\/j.survophthal.2024.05.009_bib28","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1007\/s11427-022-2288-4","article-title":"A novel MYCN-YTHDF1 cascade contributes to retinoblastoma tumor growth by eliciting m6A -dependent activation of multiple oncogenes","volume":"66","author":"Luo","year":"2023","journal-title":"Sci China Life Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.009_bib29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40246-023-00529-w","article-title":"Genetics in ophthalmology: molecular blueprints of retinoblastoma","volume":"17","author":"Markovi\u0107","year":"2023","journal-title":"Hum Genom"},{"issue":"2","key":"10.1016\/j.survophthal.2024.05.009_bib30","doi-asserted-by":"crossref","first-page":"438","DOI":"10.18632\/oncotarget.1686","article-title":"RB1 gene inactivation by chromothripsis in human retinoblastoma","volume":"5","author":"McEvoy","year":"2014","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.survophthal.2024.05.009_bib31","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1101\/gad.981002","article-title":"Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells","volume":"16","author":"Paddison","year":"2002","journal-title":"Genes Dev"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.009_bib32","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1080\/13816810.2021.1923038","article-title":"MYCN amplification levels in primary retinoblastoma tumors analyzed by Multiple Ligation-dependent Probe Amplification","volume":"42","author":"Price","year":"2021","journal-title":"Ophthalmic Genet"},{"issue":"13","key":"10.1016\/j.survophthal.2024.05.009_bib33","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/onc.2016.350","article-title":"MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation","volume":"36","author":"Qi","year":"2017","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.009_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100188","article-title":"High- Level MYCN-Amplified RB1-Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures","volume":"2","author":"Roohollahi","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.survophthal.2024.05.009_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(13)70045-7","article-title":"Characterisation of retinoblastomas without RB1 mutations: Genomic, gene expression, and clinical studies","volume":"14","author":"Rushlow","year":"2013","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.survophthal.2024.05.009_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/iovs.61.14.8","article-title":"Silencing of the long noncoding RNA MYCNOS1 suppresses activity of MYCN-amplified retinoblastoma without RB1 mutation","volume":"61","author":"Saengwimol","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.survophthal.2024.05.009_bib37","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1080\/02841860802342382","article-title":"Genomic differences between retinoma and retinoblastoma","volume":"47","author":"Sampieri","year":"2008","journal-title":"Acta Oncol"},{"issue":"10","key":"10.1016\/j.survophthal.2024.05.009_bib38","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.3390\/ijms24108606","article-title":"Simultaneous copy number alteration and single-nucleotide variation analysis in matched aqueous humor and tumor samples in children with retinoblastoma","volume":"24","author":"Schmidt","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2024.05.009_bib39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.yexcr.2018.12.018","article-title":"Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines","volume":"375","author":"Schwermer","year":"2019","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.survophthal.2024.05.009_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114554","article-title":"Piperlongumine inhibits proliferation and oncogenic MYCN expression in chemoresistant metastatic retinoblastoma cells directly and through extracellular vesicles","volume":"161","author":"Shi","year":"2023","journal-title":"Biomed Pharm"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.009_bib41","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/cells10051102","article-title":"Chromothripsis-explosion in genetic science","volume":"10","author":"Shorokhova","year":"2021","journal-title":"Cells"},{"issue":"28","key":"10.1016\/j.survophthal.2024.05.009_bib42","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200721119","article-title":"An immature, dedifferentiated, and lineage-deconstrained cone precursor origin of N-Myc-initiated retinoblastoma","volume":"119","author":"Singh","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.009_bib43","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.3390\/ijms23052805","article-title":"miRNAs in cancer (review of literature)","volume":"23","author":"Smolarz","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2024.05.009_bib44","first-page":"197","article-title":"Genetics and molecular diagnostics in retinoblastoma--an update","volume":"6","author":"Soliman","year":"2017","journal-title":"Asia Pac J Ophthalmol (Philos)"},{"issue":"20","key":"10.1016\/j.survophthal.2024.05.009_bib45","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.3390\/cancers13205248","article-title":"The oncogene MYCN modulates glycolytic and invasive genes to enhance cell viability and migration in human retinoblastoma","volume":"13","author":"Sradhanjali","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.009_bib46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13046-023-02608-1","article-title":"Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids","volume":"42","author":"Srimongkol","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"issue":"1-2","key":"10.1016\/j.survophthal.2024.05.009_bib47","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/08820538.2015.1115257","article-title":"Updates on the molecular pathology of selected ocular and ocular adnexal tumors: potential targets for future therapy","volume":"31","author":"Stagner","year":"2016","journal-title":"Semin Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.009_bib48","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1039\/C8TX00079D","article-title":"Shikonin-mediated up-regulation of miR-34a and miR-202 inhibits retinoblastoma proliferation","volume":"7","author":"Su","year":"2018","journal-title":"Toxicol Res (Camb)"},{"issue":"7","key":"10.1016\/j.survophthal.2024.05.009_bib49","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3390\/cancers15072144","article-title":"Lipid metabolic reprogramming in embryonal neoplasms with MYCN amplification","volume":"15","author":"Talapatra","year":"2023","journal-title":"Cancers (Basel )"},{"key":"10.1016\/j.survophthal.2024.05.009_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.563156","article-title":"Reciprocal Induction of MDM2 and MYCN in neural and neuroendocrine cancers","volume":"10","author":"Tran","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.survophthal.2024.05.009_bib51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4137\/BBI.S21742","article-title":"Computational and in vitro investigation of mirna-gene regulations in retinoblastoma pathogenesis: miRNA mimics strategy","volume":"9","author":"Venkatesan","year":"2015","journal-title":"Bioinform Biol Insights"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.009_bib52","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jamaophthalmol.2020.0427","article-title":"Genomic and transcriptomic tumor heterogeneity in bilateral retinoblastoma","volume":"138","author":"Winter","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.009_bib53","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1172\/JCI88508","article-title":"A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence","volume":"127","author":"Wu","year":"2017","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.survophthal.2024.05.009_bib54","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3390\/cancers13061282","article-title":"Establishing the clinical utility of ctDNA analysis for diagnosis, prognosis, and treatment monitoring of retinoblastoma: the aqueous humor liquid biopsy","volume":"13","author":"Xu","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.009_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2023.194964","article-title":"Effect of CDK7 inhibitor on MYCN-amplified retinoblastoma","volume":"1866","author":"Xu","year":"2023","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.009_bib56","first-page":"1913","article-title":"CDK inhibitors in cancer therapy, an overview of recent development","volume":"11","author":"Zhang","year":"2021","journal-title":"Am J Cancer Res"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.009_bib57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12943-019-0979-1","article-title":"Neddylation: a novel modulator of the tumor microenvironment","volume":"18","author":"Zhou","year":"2019","journal-title":"Mol Cancer"},{"issue":"9","key":"10.1016\/j.survophthal.2024.05.009_bib58","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.3390\/cancers12092714","article-title":"Clinical, genomic, and pharmacological study of MYCN- amplified RB1 wild-type metastatic retinoblastoma","volume":"12","author":"Zugbi","year":"2020","journal-title":"Cancers (Basel)"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625724000559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625724000559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T21:17:39Z","timestamp":1725484659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625724000559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0039625724000559"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2024.05.009","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of MYCN in retinoblastoma: A review of current literature","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2024.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}